Treatment with 5-fluorouracil of 35 patients with clinical or subclinical HPV infection of the vagina.
Stefanon
B
B
National Cancer Institute, Milan, Italy.
Pallucca
A
A
Merola
M
M
Bandieramonte
G
G
D000287:Administration, Topical; D000328:Adult; D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage / Q000627:therapeutic use*; D005500:Follow-Up Studies; D006801:Humans; D008875:Middle Aged; D027383:Papillomaviridae / Q000302:isolation & purification*; D030361:Papillomavirus Infections / Q000175:diagnosis / Q000188:drug therapy* / Q000473:pathology; D016896:Treatment Outcome; D014412:Tumor Virus Infections / Q000175:diagnosis / Q000188:drug therapy* / Q000473:pathology; D014623:Vaginal Diseases / Q000188:drug therapy* / Q000209:etiology / Q000473:pathology
D000964:Antimetabolites, Antineoplastic; D005472:Fluorouracil